Safety and efficacy of alpha-lipoic acid oral supplementation in the reduction of pain with unknown etiology: A monocentric, randomized, double-blind, placebo-controlled clinical trial

Introduction: Extensive evidence suggests that alpha-lipoic acid (ALA) is effective in diabetic neuropathy pain management. However, little is known on its safety and efficacy in reducing idiopathic pain in normoglycemic subjects. The aim of this study was to evaluate ALA food supplement safety and...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Cristina Esposito, Emanuele Ugo Garzarella, Cristina Santarcangelo, Alessandro Di Minno, Marco Dacrema, Roberto Sacchi, Gaetano Piccinocchi, Roberto Piccinocchi, Maria Daglia
Format: article
Langue:EN
Publié: Elsevier 2021
Sujets:
Accès en ligne:https://doaj.org/article/60801cb3d096463699e3c8ae39776fd7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires